Peritus supports Pharma, Biotech, and MedTech teams with strategy, program leadership, development, industrialisation, and due diligence across inhalation and injection systems.
years in the medical device industry
years Peritus Consulting (est. 2010)
patents (career total)
delivery: USA, Europe, India
Figures reflect founder experience across roles and programs.
Comprehensive medical device expertise from concept through commercialisation.
Deep expertise across respiratory and injectable delivery systems.
Four decades of leadership across device development, strategy, and commercialisation.
Peritus Consulting Limited
Development services, due diligence, market/strategic analysis, device evaluation, roadmapping, and business leadership for medical device and pharmaceutical industry.
Novartis Pharmaceuticals UK Ltd
Bridged device development groups and senior management. Created comprehensive 7-year device development roadmaps for respiratory pipeline.
Cambridge Consultants Limited
Led commercial strategy and drug delivery innovation. Successfully licensed inhalation technology portfolio to pharmaceutical companies.
IVAX Pharmaceuticals UK Ltd
Led global device development and commercialisation of inhalation delivery systems. Managed £12m Singapore scale-up project.
Representative examples of project impact and results.
Complex electro-mechanical injection product to deliver high viscosity medication.
Fully understand the complex nature of the patient and system requirements. Design details for a product that is re-useable whilst maintaining the simplicity of use for the patient. Combining state of the art electronics that provide ease of use for the patient or caregiver. Supplier interactions to design, manufacture, test and productionise a product in a short time period and finally launch into the market.
A truly innovative product that provided patient ease of use, launched ahead of schedule utilising suppliers from across the globe.
Need for device roadmap aligned to pipeline
Built 7-year roadmap with skills, cost, and regulatory phases
Senior leadership decision-making framework established
Industrialisation readiness assessment required
Tooling/assembly strategy, vendor assessment, DFM/DFA improvements
Manufacturing risk significantly reduced pre-launch
Technology licensing opportunity
Comprehensive business case, market positioning, investor presentations
Technology licensed to major pharmaceutical company
Supplier audit and quality concerns
Technical and regulatory audit, risk mitigation plan
Supplier relationship strengthened, quality issues resolved
Examples are anonymised and representative.
Brian was the driving force behind delivering an autoinjector for Cimzia patients. His generosity, support and impact over the years have been exceptional.David HarrisonBusiness Leader
Brian led our drug delivery business for three years from late 2004 until the end of 2007. During that time, he took the business to the next level by growing the team and extending our client list. He also championed some innovations which have been very commercially successful and his nose for the value of an innovation is impressive. What has been remarkable has been the durability of what he built which has continued to go from strength to strength since he moved on.Alan RichardsonRetired — senior to Brian in drug delivery
Book a short consult to map risks, next steps, and a clear plan.